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Chronic obstructive pulmonary disease
has become one of the more common problems which face physicians both in inpatient
and outpatient settings. The incidence of the
disease and increase in mortality have been
documented in a number of studies as have
other lung diseases, indicating a general rise in
pulmonary disorders over the past several decades. 1- 3 Two types of disease are classified under the heading of chronic pulmonary disease:
chronic bronchitis and pulmonary emphysema .
Chronic bronchitis is defined as a clinical syndrome of cough and sputum production for
three consecutive months over two consecutive
years , and pulmonary emphysema is defined as
the histological expansion and destruction of
the terminal respiratory units, with loss of structural elements. The etiologies associated with
these diseases probably are multiple and are
beyon'd the scope of this discussion; however,
two of the causal factors are a hereditary predisposition such as is seen in alpha1-antitrypsin
deficiency and the continued irritation of respiratory tissues by various air pollutants including tqbacco smoke .4
The following discussion of a therapeutic
program for those who suffer from chronic obstructive pulmonary disease is directed toward
the possibility of maintaining a patient in an outpatient status because of the need to minimize
health care costs . 1 - 5
The pathogenetic mechanisms of respiraCorrespondence and reprint requests to Dr. James P.
Baker, Director, Pulmonary Care Unit, Norfolk General Hospital, 60 0 Gresham Drive , Norfolk , VA 23507

tory distress associated with chronic obstructive
pulmonary disease share several common denominators (Fig 1 ). The primary problem is airways or bronchial obstruction, thus the physician should attempt to relieve this condition to
prevent the cascade of effects that may occur
later in the course of the illness. Obviously,
bronc:-hial irritation and infection lead to bronchial edema , spasm and hypersecretion with resulting bronchial obstruction . This can cause a
number of difficulties the more important of
which are problems of pulmonary infection and
atelectasis, ventilation-perfusion disturbances
with consequent hypoxemia, hypercapnea, and
ultimately cardiovascular death, primarily from
arrhythmias. The series of steps that can be
taken to avoid the natural progression of these
problems to mortality are outlined in the Table .
A major concern for patients with chronic
pulmonary illness is the necessity of being reassured that their physician is taking an active interest in the treatment and follow-up care of
their case . While there is no total cure for
people with chronic pulmonary disease, a reasonable lifestyle can be maintained in most
cases where the physician is ready to present
an optimistic outlook and offer encouragement
in those aspects of treatment that require the
patient's cooperation. Such guidance is an important therapeutic factor in combating this illness and provides significant satisfaction to the
physician for the time and interest expended .
Patients with chronic pulmonary disease
must avoid respiratory irritants; first of all they
must stop smoking . There is ample evidence
that while people who have pulmonary impairMCV QUARTERLY 15(3):87-90, 1979 /
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Fig 1-Pathogenesis of respiratory failure in chronic obstructive pulmonary disease . Remediable aspects in capitals.

ment and stop smoking continue to have an
FEV1 that is less than predicted for their size
and age, the rate of decline in lung function is
significantly slowed .7 This is one of the more difficult aspects of treatment to accept and many
patients deny that not smoking is of value. It is
important that the physician continue to encourage these people not to smoke , and to maintain
follow-up of those who will not stop . In addition
to cigarette smoking, patients should avoid
other known environmental respiratory irritants
as well as any inhaled allergens if they are
known and can be documented. One of the
most important aspects of a therapeutic program is to provide these patients with a home
that is as free from irritants and allergens as
possible : pets should be kept outdoors; dust
generators should be removed from the bedroom, as this is where the patient spends the
most time ; nonallergenic pillows and bedclothes
should be purchased; and all animal and cotton
products should be removed from the bedroom
if possible and only synthetic, nonallergenic fibers used in rugs, upholstered furniture, draperies , and other items. Consideration should be
given to purchasing an air filter for the bedroom
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as well as one for the entire home if simpler
measures are ineffective.
The atmospheric environment should be
controlled at between 40% and 60% relative
humidity. In addition to this , patients with
chronic pulmonary disease should drink large
quantities of liquid each day to assist in
liquefying the great amount of thickened secretions that their lungs produce; a good rule of
thumb is 1 2 to 1 4 glasses of water daily or an
adequate amount of water to dilute urine to the
point that it looks like water. A vaporizer at
times of increasing respiratory secretions such
as with an upper respiratory infection may also
be useful .
Bronchial drainage measures should be
practiced using a simple four-position technique; three of these positions are illustrated in
Figure 2. 5 The patient lies with hips elevated
above the shoulders in each position (in addition
to face-up) for 5 minutes twice daily. If.a family
member can be taught chest percussion and/
or vibration , this can assist in the removal of the
increased tenacious secretions . The next procedure is to teach the patient pursed-lip breathing
which requires that the patient exhale through

pursed lips as though he or she were whistling.
This will slow respiratory rate and may maintain
airways in an open position for a longer time
during exhalation , thus decreasing air-trapping
and improving ventilation-perfusion relationships.
Since many severe pulmonary difficulties
begin with upper respiratory infections, these
chronically-ill patients should be instructed to
keep antibiotics such as tetracycline or ampicillin in their home, and to start on these drugs as
they develop either an upper respiratory infection or a change in sputum color or quantity
which suggests an increase in infection . The patient 's physician should then be called and, depending upon the degree of difficulty the patient
is having, the physician should have a Gram
stain and/ or culture done of the patient's sputum .3
The regular use of bronchodilators is a
cornerstone of therapy for chronic pulmonary
disease. 3 · 5 6 Patients must be encouraged to
take their' drugs daily even though their condition is quiescent. The newer anhydrous aminophyllin preparations are generally the best available. The addition of sympathomimetics such
as terbutaline or metaproterenol is appropriate if
further bronchodilation is needed. Inhaled
bronchodilators are also helpful, but they should
be used infrequently, as these drugs are easily
overused. Patients taking inhaled drugs must be
given careful instructions with a demonstration
of their proper use. The nebulizer is positioned
just distal to the open mouth and a deep breath,
followed by complete exhalation, is accomplished to time appropriately the introduction of
the medication at the beginning of the next inspiration; at the onset of this inspiration the
medication is nebulized via the open mouth.
The patient holds his or her breath for as long
as possible following a maximal inspiration and
slowly exhales through pursed lips. This process should be repeated two to three times with
two to three puffs of bronchodilator each time.
Patients should be taught to monitor their pulse
rate and rhythm when taking this type of medication and to discontinue its use if they develop
any arrhythmia or tachycardia.
Another classification of drugs considered
for therapeutic use is the adrenal corticosteroids
which may be given either in inhaled or oral
forms with the inhaled form producing fewer
side affects. The introduction of steroid therapy

TABLE
Chronic Obstructive Pulmonary Disease: Outpatient
Management

1.
2.
3.
4.
5.
6.
7.
8.
9.
1 0.
11 .
12.

Physician interest and frequent follow-up
Avoidance of respiratory irritants
Maintenance of adequate humidity and hydration
Practice of bronchial drainage measures
Control of infection
Regular use of bronchodilators
Use of oxygen
Use of steroids
Control of heart failure
Other drugs
Active exercise reconditioning
Patient and family education

should be based upon indication of failure of the
above-mentioned bronchodilators and antibiotic
therapy, or evidence of a clear-cut allergic disorder shown by either nasal or sputum eosinophilia or severe irritation by known allergens.
The goal of steroid therapy should be to use the
drugs in their inhaled form and if that is impossible to use minimal amounts of the oral drugs
on alternate days to decrease side effects. 8
Another drug available for use is cromolyn
sodium ; patients with definite allergic abnormalities or evidence of allergic-oriented disease are
more likely to respond to this drug. There is no
place for the use of either sedatives or tranquilizers in the treatment of chronic respiratory dis-

Fig 2-Basic positions for bronchial drainage.
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ease. These patients are generally anxious, agitated, and frustrated because of their illness
and/or the hypoxemia and / or hypercapnia
which are associated with the disease. They are
quite sensitive to most tranquilizers, particularly
the benzodiazepams (Valium , Librium , among
others), and these drugs should be avoided. A
possible drug for use is hydroxozine (Atarax ,
Vistaril) which at least in parenteral form does
have some bronchodilator effect and may be
taken as a last resort in small doses (1 0 mg ,
t.i.d.) after all other possibilities have been exhausted.
Many patients will have observable evidence of right heart failure or cor pulmonale
which should respond to the therapeutic regimen suggested above; if they do not, first, diuretics should be tried, and if they are unsucessful, digitalis may be used. Digitalis generally does not improve right heart failure as much
as left heart failure, although it does have some
effect. It is important to avoid drugs which block
the effectiveness of beta adrenergic stimulation,
particularly propranolol which is a beta 1- and
2-blocker, as they will make the bronchodilators
less effective. An effective beta 1-blocker drug
may be available in the not-too-distant future
which will permit bronchial dilatation while controlling cardiac arrhythmias without producing
the kind of problem one regularly sees with beta
1- and 2-blockade.
Active exercise reconditioning is of great
importance for patients with chronic pulmonary
disease. 1 - 3 · 5 · 5 They should begin with a regular
walking program in which goals are set, such as
walking a number of blocks (or other measured
distance) daily in a specified period of time, with
a planned increase in the rate of walking or a
decrease in the amount of time it takes to cover
a certain distance. In addition to this, having an
exercise bicycle for indoor use during inclement
weather is of extreme importance. Exercise with
nasal oxygen may increase the exercise tolerance of the patient and permit more rapid progress; its use in the outpatient setting has been
demonstrated to be of significant value in reducing pulmonary hypertension and improving the
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psychological status of chronically hypoxemic
patients. 9
In conclusion, an educational program in
which the family as well as the patient is provided with information concerning the etiology
of the disease is very important; a similar one
which explains the pathogenetic mechanisms
involved in the illness, what the course and
prognosis are likely to be, as well as the rationale for all therapeutic measures introduced, is
also very helpful. This type of approach will assist most patients to improve and function more
effectively.
Figure 2 is reprinted with permission from Dr. Irwin
Kass.
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